tiprankstipranks
Trending News
More News >
Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
US Market

Clinigence Holdings (NUTX) Stock Forecast & Price Target

Compare
389 Followers
See the Price Targets and Ratings of:

NUTX Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Clinigence
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NUTX Stock 12 Month Forecast

There Are No Analyst Ratings for NUTX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

NUTX Financial Forecast

NUTX Earnings Forecast

Next quarter’s earnings estimate for NUTX is $5.48 with a range of $5.48 to $5.48. The previous quarter’s EPS was $3.11. NUTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year NUTX has Performed in-line its overall industry.
Next quarter’s earnings estimate for NUTX is $5.48 with a range of $5.48 to $5.48. The previous quarter’s EPS was $3.11. NUTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year NUTX has Performed in-line its overall industry.

NUTX Sales Forecast

Next quarter’s sales forecast for NUTX is $257.20M with a range of $257.20M to $257.20M. The previous quarter’s sales results were $151.68M. NUTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year NUTX has Performed in-line its overall industry.
Next quarter’s sales forecast for NUTX is $257.20M with a range of $257.20M to $257.20M. The previous quarter’s sales results were $151.68M. NUTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year NUTX has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on NUTX
Maxim Group
Maxim Group
$205$230
Buy
24.93%
Upside
Reiterated
11/25/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: AbbVie (NYSE: ABBV) and Clinigence Holdings (NASDAQ: NUTX)
Benchmark Co. Analyst forecast on NUTX
Benchmark Co.
Benchmark Co.
$300
Buy
62.95%
Upside
Reiterated
11/20/25
Clinigence Holdings (NUTX) Gets a Buy from Benchmark Co.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on NUTX
Maxim Group
Maxim Group
$205$230
Buy
24.93%
Upside
Reiterated
11/25/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: AbbVie (NYSE: ABBV) and Clinigence Holdings (NASDAQ: NUTX)
Benchmark Co. Analyst forecast on NUTX
Benchmark Co.
Benchmark Co.
$300
Buy
62.95%
Upside
Reiterated
11/20/25
Clinigence Holdings (NUTX) Gets a Buy from Benchmark Co.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Clinigence Holdings

3 Months
xxx
Success Rate
5/15 ratings generated profit
33%
Average Return
-6.73%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -6.73% per trade.
1 Year
Bill SutherlandBenchmark Co.
Success Rate
6/15 ratings generated profit
40%
Average Return
+74.69%
reiterated a buy rating 4 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +74.69% per trade.
2 Years
xxx
Success Rate
9/15 ratings generated profit
60%
Average Return
+151.49%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +151.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NUTX Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
4
3
3
0
0
Buy
45
49
71
64
48
Hold
9
7
5
0
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
58
59
79
64
59
In the current month, NUTX has received 48 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. NUTX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

NUTX Stock Forecast FAQ

What is NUTX’s average 12-month price target, according to analysts?
Currently, no data Available
What is NUTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for NUTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is NUTX a Buy, Sell or Hold?
      Currently, no data Available
      What is Clinigence Holdings Inc’s price target?
      Currently, no data Available
      What do analysts say about Clinigence Holdings Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of NUTX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.